These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10993010)

  • 1. [True and presumed contraindications of beta blockers. Peripheral vascular disease, diabetes mellitus, chronic bronchopneumopathy].
    Pozzi R
    Ital Heart J Suppl; 2000 Aug; 1(8):1031-7. PubMed ID: 10993010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice.
    Ormiston TM; Salpeter SR
    Heart Fail Monit; 2003; 4(2):45-54. PubMed ID: 14724718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioselective beta-blocker use in patients with reversible airway disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2001; 2002(2):CD002992. PubMed ID: 11406056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioselective beta-blockers for reversible airway disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2002; (4):CD002992. PubMed ID: 12519582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
    Glaab T; Weiss T
    Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Sirak TE; Jelic S; Le Jemtel TH
    J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma.
    Chen J; Radford MJ; Wang Y; Marciniak TA; Krumholz HM
    J Am Coll Cardiol; 2001 Jun; 37(7):1950-6. PubMed ID: 11401137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential therapy with beta blockers. What is their value, what are the risks?].
    Bäumer AT; Erdmann E
    MMW Fortschr Med; 2001 Sep; 143(39):36-8. PubMed ID: 11680926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment.
    Lama PJ
    Am J Ophthalmol; 2002 Nov; 134(5):749-60. PubMed ID: 12429254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
    Hawkins NM; Petrie MC; Macdonald MR; Jhund PS; Fabbri LM; Wikstrand J; McMurray JJ
    J Am Coll Cardiol; 2011 May; 57(21):2127-38. PubMed ID: 21596228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease].
    Karoli NA; Rebrov AP
    Kardiologiia; 2021 Oct; 61(10):89-98. PubMed ID: 34763643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
    Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
    Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta receptor blockers in patients with obstructive respiratory diseases -- risks and alternatives].
    Worth H
    Pneumologie; 2005 Dec; 59(12):858-61. PubMed ID: 16379054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Adrenoceptor blockade and pulmonary function in patients suffering from chronic obstructive lung disease.
    van Herwaarden CL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S46-50. PubMed ID: 6188919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intermittent claudication and beta-blockaders. An unfortunate combination?].
    Andreassen AK; Gullestad L; Bjørnerheim R; Forfang K; Kjekshus J
    Tidsskr Nor Laegeforen; 1995 Feb; 115(6):725-8. PubMed ID: 7900137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.